Next Biometrics Group ASA (OSTO:NEXTO) Cyclically Adjusted Revenue per Share: kr47.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NEXTO Next Biometrics Group ASA OSTO:NEXTO
33 GF Score
Price kr9.64
GF Value kr82.34
! 6 Warning Signs
View Full Analysis

What is Next Biometrics Group ASA Cyclically Adjusted Revenue per Share?

Next Biometrics Group ASA OSTO:NEXTO 33 Cyclically Adjusted Revenue per Share is kr47.51 as of Mar. 2026. GuruFocus rates OSTO:NEXTO with a GF Score™ of 33/100 and a GF Value™ of kr82.34. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Next Biometrics Group ASA's adjusted revenue per share for the three months ended in Mar. 2026 was kr0.080. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr47.51 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Next Biometrics Group ASA's average Cyclically Adjusted Revenue Growth Rate was 1.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Next Biometrics Group ASA was 0.80% per year. The lowest was 0.80% per year. And the median was 0.80% per year.

As of today (2026-07-19), Next Biometrics Group ASA's current stock price is kr9.64353. Next Biometrics Group ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr47.51. Next Biometrics Group ASA's Cyclically Adjusted PS Ratio of today is 0.20.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Next Biometrics Group ASA was 3.57. The lowest was 0.02. And the median was 2.00.


Next Biometrics Group ASA  (OSTO:NEXTo) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Next Biometrics Group ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.64353/47.51
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Next Biometrics Group ASA was 3.57. The lowest was 0.02. And the median was 2.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Next Biometrics Group ASA Cyclically Adjusted Revenue per Share Related Terms


Next Biometrics Group ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Next Biometrics Group ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Next Biometrics Group ASA Cyclically Adjusted Revenue per Share Chart

Next Biometrics Group ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.28 3.38 5.17 13.48

Next Biometrics Group ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.49 5.48 7.09 13.48 47.51

OSTO:NEXTO vs COHR, KEYS, GRMN: Cyclically Adjusted Revenue per Share Comparison

For the Scientific & Technical Instruments subindustry, Next Biometrics Group ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Biometrics Group ASA Cyclically Adjusted PS Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Next Biometrics Group ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Next Biometrics Group ASA's Cyclically Adjusted PS Ratio falls into.


OSTO:NEXTO
33GF Score
Next Biometrics Group ASA OSTO:NEXTO
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Next Biometrics Group ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Next Biometrics Group ASA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.08/141.0300*141.0300
=0.080

Current CPI (Mar. 2026) = 141.0300.

Next Biometrics Group ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 8.576 103.800 11.652
201609 8.256 104.200 11.174
201612 9.130 104.400 12.333
201703 6.082 105.000 8.169
201706 6.373 105.800 8.495
201709 6.749 105.900 8.988
201712 6.539 106.100 8.692
201803 6.259 107.300 8.227
201806 6.587 108.500 8.562
201809 7.693 109.500 9.908
201812 6.563 109.800 8.430
201903 3.143 110.400 4.015
201906 3.109 110.600 3.964
201909 1.821 111.100 2.312
201912 0.954 111.300 1.209
202003 2.126 111.200 2.696
202006 1.338 112.100 1.683
202009 1.084 112.900 1.354
202012 0.615 112.900 0.768
202103 0.892 114.600 1.098
202106 0.557 115.300 0.681
202109 0.721 117.500 0.865
202112 0.818 118.900 0.970
202203 0.606 119.800 0.713
202206 0.651 122.600 0.749
202209 0.864 125.600 0.970
202212 0.668 125.900 0.748
202303 0.402 127.600 0.444
202306 0.413 130.400 0.447
202309 0.342 129.800 0.372
202312 0.812 131.900 0.868
202403 0.658 132.600 0.700
202406 0.964 133.800 1.016
202409 1.382 133.700 1.458
202412 0.680 134.800 0.711
202503 0.362 136.100 0.375
202506 -0.099 137.800 -0.101
202509 0.135 138.500 0.137
202512 0.109 139.100 0.111
202603 0.080 141.030 0.080

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr47.51 mean?
Next Biometrics Group ASA (OSTO:NEXTO) has a Cyclically Adjusted Revenue per Share of kr47.51 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Next Biometrics Group ASA and its competitors.
Is Next Biometrics Group ASA's Cyclically Adjusted Revenue per Share too high?
Next Biometrics Group ASA's current Cyclically Adjusted Revenue per Share is kr47.51. Overall, Next Biometrics Group ASA has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Next Biometrics Group ASA's Cyclically Adjusted Revenue per Share compare to COHR and KEYS?
Next Biometrics Group ASA's Cyclically Adjusted Revenue per Share of kr47.51 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Hardware company?
A good Cyclically Adjusted Revenue per Share depends on the Hardware industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Next Biometrics Group ASA and its competitors. Next Biometrics Group ASA's current Cyclically Adjusted Revenue per Share is kr47.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Next Biometrics Group ASA stock overvalued right now?
Next Biometrics Group ASA (OSTO:NEXTO) has a current Cyclically Adjusted Revenue per Share of kr47.51. The stock's GF Value™ is kr82.34, compared to a current price of kr9.64 — trading 88.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr47.51. Next Biometrics Group ASA's overall GF Score™ is 33/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Next Biometrics Group ASA (OSTO:NEXTO), the current Cyclically Adjusted Revenue per Share is kr47.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Next Biometrics Group ASA (OSTO:NEXTO) Overvalued in 2026?

Based on GuruFocus' analysis, Next Biometrics Group ASA stock appears to be undervalued. The current stock price of kr9.64 is trading 88.3% below its estimated GF Value™ of kr82.34.

Key valuation signals for OSTO:NEXTO:

  • Cyclically Adjusted Revenue per Share: kr47.51
  • GF Value™: kr82.34 vs. price of kr9.64 (88.3% below fair value)
  • GF Score™: 33/100 with 6 warning signs

No single metric tells the full story. See the OSTO:NEXTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Next Biometrics Group ASA Business Description

Other Exchanges NEXT:Norway0QWK:UK
Address Stortorvet 7, Oslo, NOR, 0155
Next Biometrics Group ASA provides fingerprint sensor technology and products. The company's products are utilized for Smart Card, Government ID, Access control, Notebook, and others. The company's products include smart card solutions, fingerprint sensor modules, fingerprint readers, Aadhar products, Software DevKits, and Hardware DevKits. The company has one operating segment namely; Fingerprint sensor Technology. The company's Geographic customer base consists of Asia (Japan and India), Europe (France and Germany) and North America.
33GF Score

Get the complete analysis for OSTO:NEXTO

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.64
Price
kr82.34
GF Value